Home › NDC Lookup › RxCUI directory › RxCUI 1000154

1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [Depo-Provera] — RxCUI 1000154

RxNorm drug concept · Semantic branded drug
RxCUI 1000154 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1000154
Official name1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [Depo-Provera]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Depo-Provera 150 MG/ML Prefilled Syringe; Depo-Provera 150 MG in 1 ML Prefilled Syringe; Depo-Provera 150 MG per 1 ML Prefilled Syringe
FDA products mapped2
Package NDCs mapped3
Reported Medicaid activity (SDUD)46,832 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Medroxyprogesterone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It prevents pregnancy. Depo-subQ Provera 104 is also used to manage pain from endometriosis. A healthcare professional gives it, so you do not inject it yourself.
  • Depo-subQ Provera 104 is given about every 12 to 14 weeks. If you cannot get it in that window, use another birth control method until your next injection. If more than 14 weeks pa...
  • Changes in your bleeding pattern are the most common, including spotting, irregular bleeding or no periods at all. Headache, weight gain and injection site soreness or lumps can al...
  • This medicine can lower bone density, and the loss may not fully come back. That is why it is generally not recommended for more than 2 years unless other options are inadequate. T...
📖 Read our full Medroxyprogesterone Injection guide →

🕸️ Concept Web — How 1 ML medroxyprogesterone acetate 150 MG/ML Prefi... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [Depo-Provera] RxCUI 1000154

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Medroxyprogesterone 6691
    • Medroxyprogesterone acetate 1000112
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Depo-Provera 202886
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Medroxyprogesterone Prefilled Syringe 727610
    • Medroxyprogesterone acetate Prefilled Syringe 2645568
    • Medroxyprogesterone Injectable Product 1159192
    • Medroxyprogesterone acetate Injectable Product 2661863
    • Medroxyprogesterone Prefilled Syringe [Depo-Provera] 791057
    • Medroxyprogesterone acetate Prefilled Syringe [Depo-Provera] 2654178
    • Depo-Provera Injectable Product 1173112
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe SCD · 1000153
  • Medroxyprogesterone acetate 150 MG/ML SCDC · 1000125
  • Medroxyprogesterone Prefilled Syringe SCDF · 727610
  • Medroxyprogesterone acetate Prefilled Syringe SCDFP · 2645568
  • Medroxyprogesterone Injectable Product SCDG · 1159192
  • Medroxyprogesterone acetate Injectable Product SCDGP · 2661863

Brand-Name Concepts

  • Medroxyprogesterone acetate 150 MG/ML [Depo-Provera] SBDC · 1000127
  • Medroxyprogesterone Prefilled Syringe [Depo-Provera] SBDF · 791057
  • Medroxyprogesterone acetate Prefilled Syringe [Depo-Provera] SBDFP · 2654178
  • Depo-Provera Injectable Product SBDG · 1173112
  • Depo-Provera BN · 202886

📦 FDA Products & Package NDCs

2 products · 3 package NDCs
3 package NDCs map to RxCUI 1000154 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00009-0746-30 1 VIAL in 1 CARTON (0009-0746-30) / 1 mL in 1 VIAL Depo-Provera Pharmacia & Upjohn Company LLC 1992-10-29
00009-0746-35 25 VIAL in 1 PACKAGE (0009-0746-35) / 1 mL in 1 VIAL Depo-Provera Pharmacia & Upjohn Company LLC 1992-10-29
00009-7376-11 1 SYRINGE in 1 CARTON (0009-7376-11) / 1 mL in 1 SYRINGE Depo-Provera Pharmacia & Upjohn Company LLC 1992-10-29
Observed labelers: Pharmacia & Upjohn Company LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$51.7195
Range $50.9940–$52.4450 · middle 50% $51.3568–$52.0823 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.